Question 1

What is the catalog number for 3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide?

Accepted Answer

The catalog number for 3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide is URB83724.

Question 2

What sizes are available for 3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide?

Accepted Answer

3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide is available in the following size(s): 250 mg, 2.5 g.

Question 3

How many pack sizes does 3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide come in?

Accepted Answer

3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide is available in 2 different pack sizes.

Question 4

Is 3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide in stock?

Accepted Answer

3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 7

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

3- (2,5-Dimethylphenyl) -1H-pyrazole-5-carbohydrazide

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

CD86 (BU63), CF647 conjugate, 0.1mg/mL

CD44 Standard (156-3C11), CF740 conjugate, 0.1mg/mL

CD3e (RIV9), CF568 conjugate, 0.1mg/mL

GCDFP-15 (Gross Cystic Disease Fluid Protein 15) (Breast Marker) (PIP/1571), CF488A conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF647 conjugate, 0.1mg/mL

CD45RA (111-1C5), CF640R conjugate, 0.1mg/mL